Tag: obesity drugs
Novo Nordisk’s Diabetes and Obesity Drug Pipeline Still Strong, Bernstein Says
Bernstein Reiterates Outperform on Novo Nordisk: GLP-1 Portfolio Still Strong
Bernstein has reaffirmed its Outperform rating on Novo Nordisk, saying the company’s GLP-1 drug portfolio...




